Factors affecting the stability of L-glutamine in solution
- PMID: 16839917
- DOI: 10.1016/0261-5614(91)90037-d
Factors affecting the stability of L-glutamine in solution
Abstract
The degradation rate of L-glutamine in water, various buffers, and intravenous solutions was assessed over a period of 2 weeks. Measurements were made at various temperatures (22-24 degrees C, and 4 degrees C and -80 degrees C) and pH, and also in the presence and absence of light and oxygen (intravenous solutions only). At 22-24 degrees C, the degradation rate of glutamine was variable depending on the type of solution used (0.23% in water pH 6.5; 0.22% in dextrose/water [15% w/v]; 0.8% in mixed total parenteral nutrition (TPN) solution), and on the pH, molarity and type of buffer used. The degradation rate was essentially unaffected by light and O(2). The degradation rate of L-glutamine in the intravenous solutions was less than 0.15%/day at 4 degrees C, minimal at -20 degrees C (<0.03%/day), and undetectable at -80 degrees C. Glutamine degradation resulted in the equimolar formation of ammonia and no associated formation of glutamate. It is concluded that (a) glutamine degradation in solution is variable due to the effect of physico-chemical factors, and (b) glutamine degradation in TPN solutions is sufficiently slow, especially during storage at 4 degrees C or below, to consider its inclusion in such solutions, for clinical use.
Similar articles
-
The stability of L-glutamine in total parenteral nutrition solutions.Clin Nutr. 1991 Aug;10(4):193-8. doi: 10.1016/0261-5614(91)90038-e. Clin Nutr. 1991. PMID: 16839918
-
Stability studies of lincomycin hydrochloride in aqueous solution and intravenous infusion fluids.Drug Des Devel Ther. 2016 Mar 7;10:1029-34. doi: 10.2147/DDDT.S94710. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27022242 Free PMC article.
-
L-glutamine supplementation in home total parenteral nutrition patients: stability, safety, and effects on intestinal absorption.JPEN J Parenter Enteral Nutr. 1994 May-Jun;18(3):268-73. doi: 10.1177/0148607194018003268. JPEN J Parenter Enteral Nutr. 1994. PMID: 8065004
-
Stress-induced intracellular glutamine depletion. The potential use of glutamine-containing peptides in parenteral nutrition.Beitr Infusionther Klin Ernahr. 1987;17:117-36. Beitr Infusionther Klin Ernahr. 1987. PMID: 3120690 Review.
-
[Administration of glutamine and its dipeptides in parenteral nutrition. Which patients are candidates?].Nutr Hosp. 1998 Jan-Feb;13(1):8-20. Nutr Hosp. 1998. PMID: 9578682 Review. Spanish.
Cited by
-
Stability of Minimum Essential Medium functionality despite L-glutamine decomposition.Cytotechnology. 2016 Aug;68(4):1171-83. doi: 10.1007/s10616-015-9875-8. Epub 2015 Apr 24. Cytotechnology. 2016. PMID: 25904557 Free PMC article.
-
Interaction of Atmospheric-Pressure Air Microplasmas with Amino Acids as Fundamental Processes in Aqueous Solution.PLoS One. 2016 May 16;11(5):e0155584. doi: 10.1371/journal.pone.0155584. eCollection 2016. PLoS One. 2016. PMID: 27183129 Free PMC article.
-
Evidence of a liver-alpha cell axis in humans: hepatic insulin resistance attenuates relationship between fasting plasma glucagon and glucagonotropic amino acids.Diabetologia. 2018 Mar;61(3):671-680. doi: 10.1007/s00125-017-4535-5. Epub 2018 Jan 5. Diabetologia. 2018. PMID: 29305624
-
Viability of Toxoplasma gondii tachyzoites in different conditions for parasite transportation.Vet World. 2022 Jan;15(1):198-204. doi: 10.14202/vetworld.2022.198-204. Epub 2022 Jan 29. Vet World. 2022. PMID: 35369589 Free PMC article.
-
Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial.Gut. 2001 Jan;48(1):28-33. doi: 10.1136/gut.48.1.28. Gut. 2001. PMID: 11115819 Free PMC article. Clinical Trial.
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials